DJ Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 2.36% to $59.55 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.38% to 5,633.07 and the Dow Jones Industrial Average falling 0.03% to 41,989.96.
The stock's fall snapped a two-day winning streak.
Bristol Myers Squibb Co. closed 5.97% short of its 52-week high of $63.33, which the company reached on March 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 7.59% to $153.25, Pfizer Inc. $(PFE)$ fell 3.16% to $24.54, and Abbott Laboratories $(ABT)$ fell 0.72% to $131.69.
Trading volume (9.6 M) remained 2.6 million below its 50-day average volume of 12.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2025 16:38 ET (20:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。